Serotype
WikiDoc Resources for Serotype |
Articles |
---|
Most recent articles on Serotype |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Serotype at Clinical Trials.gov Clinical Trials on Serotype at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Serotype
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Serotype Risk calculators and risk factors for Serotype
|
Healthcare Provider Resources |
Causes & Risk Factors for Serotype |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
For the term's use in bacteriology, see serovar.
Serotype (Allograft)
Transplants between genetically non-identical humans induce the creation of antibodies in the recipient. These non-identical cell-surface receptors between the donor and recipient produce antiserum reactive to the donor proteins. Under selection conditions one or two isoform specificities are obtained. This results in a serotype that is capable of identifying other individuals who have those proteins. This serotyping along with new-PCR based techniques are how tissues for organ-donor programs are characterized. (for more detailed information see Human leukocyte antigens and HLA Serotype tutorial)
HLA | # of | Broad | Split |
---|---|---|---|
Locus | Serotypes | Antigens | Antigens |
A | 25 | 4 | 15 |
B | 50 | 9 | 24 |
C* | 12 | 1 | 2 |
DR | 21 | 4 | 8 |
DQ | 8 | 2 | 5 |
DP* | |||
*DP and many Cw require SSP-PCR for typing. |